RLAY (STOCKS)
Relay Therapeutics, Inc. Common Stock
$14.960000
-0.300000 (-1.97%)
Prev close: $15.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sanjiv K. Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,634.42M
- Employees
- 197
- P/E (TTM)
- -9.14
- P/B (TTM)
- 4.68
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.32 | $-0.41 | +0.0924 | +22.41% |
|
Sep 2025 (Q3)
|
$-0.43 | $-0.42 | -0.0062 | -1.46% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.50 | +0.0914 | +18.23% |
|
Mar 2025 (Q1)
|
$-0.46 | $-0.50 | +0.0378 | +7.59% |
Financial Statements
| Revenues | $15.36M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $318.09M |
| Operating Expenses | $318.09M |
| Operating Income/Loss | -$302.74M |
| Income/Loss From Continuing Operations After Tax | -$276.48M |
| Income/Loss From Continuing Operations Before Tax | $15.36M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$276.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$276.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$276.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.61 |
| Diluted Earnings Per Share | -$1.61 |
| Basic Average Shares | 171,586,558 |
| Assets | $621.33M |
| Current Assets | $578.28M |
| Prepaid Expenses | $17.79M |
| Other Current Assets | $560.49M |
| Noncurrent Assets | $43.05M |
| Fixed Assets | $1.73M |
| Other Non-current Assets | $41.33M |
| Liabilities | $54.27M |
| Current Liabilities | $25.58M |
| Accounts Payable | $7.71M |
| Other Current Liabilities | $17.87M |
| Noncurrent Liabilities | $28.69M |
| Equity | $567.06M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $567.06M |
| Liabilities And Equity | $621.33M |
| Net Cash Flow From Operating Activities | -$235.46M |
| Net Cash Flow From Operating Activities, Continuing | -$235.46M |
| Net Cash Flow From Investing Activities | $192.80M |
| Net Cash Flow From Investing Activities, Continuing | $192.80M |
| Net Cash Flow From Financing Activities | $1.60M |
| Net Cash Flow From Financing Activities, Continuing | $1.60M |
| Net Cash Flow | -$41.05M |
| Net Cash Flow, Continuing | -$41.05M |
| Comprehensive Income/Loss | -$274.76M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$274.76M |
| Other Comprehensive Income/Loss | $1.72M |